Teva reports positive skin treatment drug results
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported optimistic outcomes for TEV-’408, an investigational anti-interleukin-15 monoclonal antibody, ...
Monday, August 10, 2026
Tag: Teva
Teva beats analysts on Q3, raises guidance
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has introduced robust third quarter outcomes and calmed buyers. Regardless of ...
Teva jumps ahead of Q3 results
The share value of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 8.1% final week on Wall Avenue, ...
Prilenia signs deal for former Teva ALS drug worth up to 500m
Israeli-Dutch scientific stage biotech firm Prilenia Therapeutics has introduced a collaboration and licensing settlement for its lead drug Pridopidine, ...
Teva share price at 6-year high after trial results
The market cap of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA rose by $5 billion yesterday, after the ...
RECOMMENDED
Do college students need renters insurance?
Once you transfer into your first school dorm or residence, chances are you'll carry alongside a laptop computer, bike, cellphone,...
Copyright © 2024 PWC.